Each of these facets of CNP biology hints that the peptide may represent an intrinsic defense mechanism to prevent the development of MASH and other liver-related diseases and that targeting CNP signaling may offer a new, effective therapeutic avenue. Here, CNP is linked to metabolic dysfunction-associated steatohepatitis.